Fig. 2From: Clinical significance of serum CA125 in diffuse malignant mesotheliomaThe survival of DMPlM patients and DMPeM patients subgroups. The median survival (OS) of DMPlM patients was 6 months. The median OS of DMPeM patients subgroup was longer than 24 months, P = 0.003Back to article page